Latest Stories
Uncategorized
Schrodinger Spins Off a New Biotech Built Entirely Around Its AI Drug-Design Software
Schrodinger has co-founded Tectora Therapeutics, a $55 million Series A-backed biotech built to develop two of its own AI-designed drug candidates for immunology and inflammation.
Uncategorized
Google’s Mammography AI Beats Human Readers in Largest NHS Breast Cancer Trial Yet
A Nature Cancer study spanning over 125,000 mammograms found Google's AI outperformed human radiologists on sensitivity while matching them on specificity — the largest NHS test yet of AI in breast cancer screening.
Uncategorized
First Health Systems Earn URAC’s New AI Accreditation, Setting a National Bar for ‘Responsible AI’
Guidehealth, RediMinds and SandsRx are the first organizations to earn URAC's new Health Care AI Accreditation, a voluntary credential meant to fill the gap regulators haven't closed.
Uncategorized
Qure.ai’s Chest X-Ray AI Wins Six New FDA Clearances, Taking the Crown in Radiology
Qure.ai's qXR-Detect just won six new FDA clearances for chest X-ray findings, becoming the first such tool cleared with a plan to keep updating its algorithm without a new filing each time.
In-Depth
Uncategorized
Novo Nordisk Bets on AWS and Agentic AI to Cut Years Off Drug Discovery
Novo Nordisk has named AWS its preferred cloud and AI partner and opened a co-innovation hub in London, using tools like Amazon Bio Discovery and Bedrock to try to compress the path from drug target to first human dose, part of a broader wave of pharma-hyperscaler AI deals.
Uncategorized
Oracle’s New AI Patient Portal Explains Your Cholesterol Trends in Plain English
Oracle Health's AI-powered patient portal, now generally available across the US, lets patients ask plain-language questions about labs, medications and diabetes management directly from their EHR, with citations and highlighting meant to keep AI answers traceable rather than opaque.
Uncategorized
OpenAI Foundation Commits $125 Million to Fix AI’s Biggest Health Data Gap
The OpenAI Foundation is putting $125 million into Public Data for Health, funding open scientific datasets at UNC's cancer center, OpenADMET and CTD Commons in a bet that better biological data, not just bigger models, is the real bottleneck for AI in medicine.
Uncategorized
OpenEvidence Rolls Out a Family of Medical AI Models, Keeps Its Perfect-MedQA-Score Model Under Wraps
OpenEvidence, used daily by more than 40% of U.S. physicians, split its clinical AI chatbot into three named models for speed and depth while holding back a fourth, Darwin, which it says scored perfectly on the MedQA benchmark, citing dual-use safety risks.
Uncategorized
Elucid Raises $55 Million to Push AI Heart-Plaque Imaging Into Mainstream Cardiology
Elucid closed a $55 million Series D on September 2, 2026, bringing total funding to about $185 million to expand its FDA-cleared Plaque-IQ AI, which reads coronary CT scans to classify dangerous heart plaque, plus a new FFR-CT tool awaiting FDA review.
